Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols

Breast Cancer


Abarzua S, Serikawa T, Szewczyk M, Richter DU, Piechulla B, Briese V. Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20. Archives of gynecology and obstetrics.Apr 2012;285(4):1145-1151.

ACS. American Cancer Society: Cancer Facts and Figures 2017. 2017a. Accessed 2/8/2018.

ACS. American Cancer Society. Breast density and your mammogram report. Last updated 10/9/2017b. Accessed 2/12/2018.

ACS. American Cancer Society. Treating Bone Metastases. Last updated 12/16/2016a. Accessed 2/12/2018.

ACS. American Cancer Society. Breast reconstruction using your own tissues (flap procedures). Last updated 8/18/2016b. Accessed 2/12/2018.

Adams LS, Zhang Y, Seeram NP, Heber D, Chen S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer prevention research (Philadelphia, Pa.).Jan 2010;3(1):108-113.

Afghahi A, Kurian AW. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition. Current treatment options in oncology.May 2017;18(5):27.

Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer research.Nov-Dec 2006;26(6b):4457-4498.

Akoochakian M, Davari HA, Alizadeh MH, Rahnama N. Evaluation of shoulder girdle strength more than 12 month after modified radical mastectomy and axillary nodes dissection. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences.2017;22:81.

Ali ES, Mangold C, Peiris AN. Estriol: emerging clinical benefits. Menopause (New York, N.Y.).Apr 03 2017.

Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer research.Jul 1 2001;61(13):5045-5050.

Amaral T, Meraz-Torres F, Garbe C. Immunotherapy in managing metastatic melanoma: which treatment when? Expert Opin Biol Ther.Dec 2017;17(12):1523-1538.

Anonymous. Breast-specific gamma imaging (BSGI), molecular breast imaging (MBI), or scintimammography with breast-specific gamma camera. Technology Evaluation Center Assessment Program. Executive summary.Jun 2013;28(2):1-4.

Anonymous. Having a Breast Biopsy: A Review of the Research for Women and Their Families. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-. John M. Eisenberg Center for Clinical Decisions and Communications Science. 2016. Accessed December 19, 2017.

Antimisiaris D, Bae KG, Morton L, Gully Z. Tamoxifen Pharmacovigilance: Implications for Safe Use in the Future. The Consultant pharmacist: the journal of the American Society of Consultant Pharmacists.Sep 1 2017;32(9):535-546.

Antonilli M, Rahimi H, Visconti V, Napoletano C, Ruscito I, Zizzari IG, . . . Nuti M. Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial. International journal of oncology.Apr 2016;48(4):1369-1378.

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, . . . Easton DF. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet.May 2003;72(5):1117-1130.

Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, . . . Tischkowitz M. Breast-cancer risk in families with mutations in PALB2. The New England journal of medicine.Aug 7 2014;371(6):497-506.

Arab A, Akbarian SA, Ghiyasvand R, Miraghajani M. The effects of conjugated linoleic acids on breast cancer: A systematic review. Advanced biomedical research.2016;5:115.

Aro A, Mannisto S, Salminen I, Ovaskainen ML, Kataja V, Uusitupa M. Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutrition and cancer.2000;38(2):151-157.

Arshad Z, Karmen L, Choudhary R, Smith JA, Branford OA, Brindley DA, . . . Davies BM. Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality. JPRAS open.Dec 2016;10:5-20.

Arul Vijaya Vani S, Ananthanarayanan PH, Kadambari D, Harichandrakumar KT, Niranjjan R, Nandeesha H. Effects of vitamin D and calcium supplementation on side effects profile in patients of breast cancer treated with letrozole. Clinica chimica acta; international journal of clinical chemistry. Aug 01 2016;459:53-56.

ASCO. ASCO Editorial Board. Breast Cancer: Statistics. 4/2017. Accessed 2/12/2018.

Asfour IA, El Shazly S, Fayek MH, Hegab HM, Raouf S, Moussa MA. Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients. Biol Trace Elem Res.Apr 2006;110(1):19-32.

Atwell LL, Beaver LM, Shannon J, Williams DE, Dashwood RH, Ho E. Epigenetic Regulation by Sulforaphane: Opportunities for Breast and Prostate Cancer Chemoprevention. Current pharmacology reports.Apr 1 2015;1(2):102-111.

Autier P, Boniol M, Koechlin A, Pizot C, Boniol M. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ (Clinical research ed.).Dec 5 2017;359:j5224.

Baatjes KJ, Conradie M, Apffelstaedt JP, Kotze M. Pharmacogenetics of aromatase inhibitors in endocrine responsive breast cancer: lessons learnt from tamoxifen and CYP2D6 genotyping. Anti-cancer agents in medicinal chemistry. Apr 12 2017.

Bach A, Bender-Sigel J, Schrenk D, Flugel D, Kietzmann T. The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF. Antioxidants & redox signaling.Aug 15 2010;13(4):437-448.

Bachmeier BE, Mohrenz IV, Mirisola V, Schleicher E, Romeo F, Hohneke C, . . . Pfeffer U. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis.Apr 2008;29(4):779-789.

Bae JM. Reinterpretation of the results of a pooled analysis of dietary carotenoid intake and breast cancer risk by using the interval collapsing method. Epidemiology and health.2016;38:e2016024.

Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, . . . Avan A. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. J Cell Physiol.Feb 2018;233(2):774-786.

Balakrishnan S, Mukherjee S, Das S, Bhat FA, Raja Singh P, Patra CR, Arunakaran J. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Cell biochemistry and function.Jun 2017;35(4):217-231.

Banerjee S, Kambhampati S, Haque I, Banerjee SK. Pomegranate sensitizes Tamoxifen action in ER-alpha positive breast cancer cells. Journal of cell communication and signaling.Dec 2011;5(4):317-324.

Banerjee SM, MacRobert AJ, Mosse CA, Periera B, Bown SG, Keshtgar MRS. Photodynamic therapy: Inception to application in breast cancer. Breast (Edinburgh, Scotland).Feb 2017;31:105-113.

Banik U, Parasuraman S, Adhikary AK, Othman NH. Curcumin: the spicy modulator of breast carcinogenesis. Journal of experimental & clinical cancer research: CR.Jul 19 2017;36(1):98.

Bao PP, Zhao GM, Shu XO, Peng P, Cai H, Lu W, Zheng Y. Modifiable Lifestyle Factors and Triple-negative Breast Cancer Survival: A Population-based Prospective Study. Epidemiology (Cambridge, Mass.).Nov 2015;26(6):909-916.

Bardia A, Mayer IA, Diamond JR, Moroose RL, Isakoff SJ, Starodub AN, . . . Vahdat LT. Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology.Jul 01 2017;35(19):2141-2148.

Baron JM, Boster BL, Barnett CM. Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. J Oncol Pharm Pract.Apr 2015;21(2):132-142.

Baselga J, Campone M, Piccart M, Burris HA, 3rd, Rugo HS, Sahmoud T, . . . Hortobagyi GN. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. Feb 09 2012;366(6):520-529.

Baselga J, Coleman RE, Cortes J, Janni W. Advances in the management of HER2-positive early breast cancer. Critical reviews in oncology/hematology.Nov 2017;119:113-122.

Baumgarten SC, Frasor J. Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Molecular endocrinology (Baltimore, Md.).Mar 2012;26(3):360-371.

Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, Abrial C, . . . Chollet P. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther.Jan 2010;9(1):8-14.

Bear HD, Wan W, Robidoux A, Rubin P, Limentani S, White RL, Jr., . . . Sing AP. Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of surgical oncology. Jun 2017;115(8):917-923.

Beije N, Sieuwerts AM, Kraan J, Van NM, Wendy O, Vitale SR, . . . Sleijfer S. Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients. Molecular oncology.Oct 24 2017.

Ben-Baruch A. Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast cancer research: BCR.2003;5(1):31-36.

Ben-David MA, Elkayam R, Gelernter I, Pfeffer RM. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial. The Israel Medical Association journal: IMAJ.Mar-Apr 2016;18(3-4):188-192.

Benedetti R, Dell'Aversana C, Giorgio C, Astorri R, Altucci L. Breast Cancer Vaccines: New Insights. Frontiers in endocrinology.2017;8:270.

Bera S, De Rosa V, Rachidi W, Diamond AM. Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention? Mutagenesis.Mar 2013;28(2):127-134.

Bhattacharyya S, Md Sakib Hossain D, Mohanty S, Sankar Sen G, Chattopadhyay S, Banerjee S, . . . Sa G. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cellular & molecular immunology.Jul 2010;7(4):306-315.

Bhoo-Pathy N, Peeters PH, Uiterwaal CS, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, . . . van Gils CH. Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Breast cancer research: BCR.Jan 31 2015;17:15.

Bickelhaupt S, Paech D, Laun FB, Steudle F, Kuder TA, Mlynarska A, . . . Schlemmer HP. Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography. Clinical radiology.Oct 2017;72(10):900.e901-900.e908.

Bidad N, MacDonald L, Winters ZE, Edwards SJ, Emson M, Griffin CL, . . . Horne R. How informed is declared altruism in clinical trials? A qualitative interview study of patient decision-making about the QUEST trials (Quality of Life after Mastectomy and Breast Reconstruction). Trials.Sep 2 2016;17(1):431.

Bijak M. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism. Molecules.Nov 10 2017;22(11).

Blohmer JU, Tanko J, Kueper J, Gross J, Volker R, Machleidt A. MarginProbe(c) reduces the rate of re-excision following breast conserving surgery for breast cancer. Archives of gynecology and obstetrics.Aug 2016;294(2):361-367.

Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, van den Bosch J, . . . van de Velde CJH. Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05). J Natl Cancer Inst. Jan 01 2018;110(1).

Body JJ, Quinn G, Talbot S, Booth E, Demonty G, Taylor A, Amelio J. Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases. Critical reviews in oncology/hematology.Jul 2017;115:67-80.

Bougnoux P, Hajjaji N, Ferrasson MN, Giraudeau B, Couet C, Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. British journal of cancer. Dec 15 2009;101(12):1978-1985.

Boyages J. Radiation therapy and early breast cancer: current controversies. The Medical journal of Australia.Aug 04 2017;207(5):216-222.

Boyd NF, Martin LJ, Rommens JM, Paterson AD, Minkin S, Yaffe MJ, . . . Hopper JL. Mammographic density: a heritable risk factor for breast cancer. Methods in molecular biology (Clifton, N.J.).2009;472:343-360.

Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, . . . Wigginton JM. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med.Jun 28 2012;366(26):2455-2465.

Brem RF, Ruda RC, Yang JL, Coffey CM, Rapelyea JA. Breast-Specific gamma-Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk. J Nucl Med.May 2016;57(5):678-684.

Brennan SF, Woodside JV, Lunny PM, Cardwell CR, Cantwell MM. Dietary fat and breast cancer mortality: A systematic review and meta-analysis. Critical reviews in food science and nutrition.Jul 03 2017;57(10):1999-2008.

Briest S, Stearns V. Tamoxifen metabolism and its effect on endocrine treatment of breast cancer. Clinical advances in hematology & oncology: H&O. Mar 2009;7(3):185-192.

Bright CJ, Rea DW, Francis A, Feltbower RG. Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013. Cancer epidemiology.Oct 2016;44:186-194.

Brown GM. Light, melatonin and the sleep-wake cycle. Journal of psychiatry & neuroscience: JPN. Nov 1994;19(5):345-353.

Buck K, Zaineddin AK, Vrieling A, Heinz J, Linseisen J, Flesch-Janys D, Chang-Claude J. Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. British journal of cancer.Oct 11 2011;105(8):1151-1157.

Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, . . . Griggs JJ. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. May 10 2016;34(14):1689-1701.

Cabel L, Proudhon C, Gortais H, Loirat D, Coussy F, Pierga JY, Bidard FC. Circulating tumor cells: clinical validity and utility. International journal of clinical oncology.Jun 2017;22(3):421-430.

Calip GS, Yu O, Hoskins KF, Boudreau DM. Associations between diabetes medication use and risk of second breast cancer events and mortality. Cancer Causes Control.Aug 2015;26(8):1065-1077.

Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, . . . Piccart M. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. The New England journal of medicine.Aug 25 2016;375(8):717-729.

Carr AC. Symposium on Vitamin C, 15th September 2017; Part of the Linus Pauling Institute's 9th International Conference on Diet and Optimum Health. Antioxidants (Basel, Switzerland). Nov 21 2017;6(4).

Caruso JA, Campana R, Wei C, Su CH, Hanks AM, Bornmann WG, Keyomarsi K. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERalpha-positive breast cancer cells. Cell cycle (Georgetown, Tex.).2014;13(16):2587-2599.

Castrellon AB. Novel Strategies to Improve the Endocrine Therapy of Breast Cancer. Oncology reviews.Mar 03 2017;11(1):323.

Catsburg C, Kim RS, Kirsh VA, Soskolne CL, Kreiger N, Rohan TE. Dietary patterns and breast cancer risk: a study in 2 cohorts. The American journal of clinical nutrition.Apr 2015;101(4):817-823.

Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, Hebert JR. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. The Journal of nutrition.Dec 2009;139(12):2365-2372.

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Bandos H, . . . Wolmark N. Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR). Cancer prevention research (Philadelphia, Pa.). Nov 2012;5(11):1321-1329.

Cepa M, Vaz C. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors. Acta reumatologica portuguesa.Oct-Dec 2015;40(4):323-330.

Chamruspollert M, Sell JL. Transfer of dietary conjugated linoleic acid to egg yolks of chickens. Poultry science.Aug 1999;78(8):1138-1150.

Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clinical cancer research: an official journal of the American Association for Cancer Research.Jan 2003;9(1):10-19.

Chan TY, Tan PW, Tang JI. Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time? Breast cancer (Dove Medical Press).2017;9:177-183.

Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF. 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis.Apr 2005;26(4):771-778.

Chang Y, Zhang M, Jiang Y, Liu Y, Luo H, Hao C, . . . Zhang L. Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Discovery medicine.Apr 2017;23(127):207-219.

Chang YJ, Hou YC, Chen LJ, Wu JH, Wu CC, Chang YJ, Chung KP. Is vegetarian diet associated with a lower risk of breast cancer in Taiwanese women? BMC Public Health.Oct 10 2017;17(1):800.

Charehbili A, Hamdy NA, Smit VT, Kessels L, van Bochove A, van Laarhoven HW, . . . Kroep JR. Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01). Breast (Edinburgh, Scotland).Feb 2016;25:69-74.

Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, . . . Martin SS. Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer research.Feb 15 2014;74(4):1250-1260.

Chen D, Landis-Piwowar KR, Chen MS, Dou QP. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast cancer research: BCR.2007;9(6):R80.

Chen WZ, Shen JF, Zhou Y, Chen XY, Liu JM, Liu ZL. Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer. Sci Rep.Sep 12 2017;7(1):11325.

Cheng J, Cuk K, Heil J, Golatta M, Schott S, Sohn C, . . . Surowy H. Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence. Oncotarget.Aug 15 2017;8(33):54537-54547.

Chevrier MC, David J, Khoury ME, Lalonde L, Labelle M, Trop I. Breast Biopsies Under Magnetic Resonance Imaging Guidance: Challenges of an Essential but Imperfect Technique. Current problems in diagnostic radiology.May-Jun 2016;45(3):193-204.

Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pacific journal of cancer prevention: APJCP.2013;14(4):2407-2412.

Chlebowski RT, Aragaki AK, Anderson GL, Thomson CA, Manson JE, Simon MS, . . . Prentice RL. Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology.Sep 01 2017;35(25):2919-2926.

Cho N, Han W, Han BK, Bae MS, Ko ES, Nam SJ, . . . Moon WK. Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy. JAMA Oncol.Jun 22 2017.

Choi EJ, Kim GH. 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells. Oncology reports.Dec 2009;22(6):1533-1537.

Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, . . . Macaskill P. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. The Lancet. Oncology.Jun 2013;14(7):583-589.

Cleveland Clinic. Breast Self-Exam: Test Details. 6/20/2015. Accessed 2/12/2018.

Clifton GT, Gall V, Peoples GE, Mittendorf EA. Clinical Development of the E75 Vaccine in Breast Cancer. Breast care (Basel, Switzerland).Apr 2016;11(2):116-121.

Cobin RH, Goodman NF. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.Jul 2017;23(7):869-880.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet.Jul 20 2002;360(9328):187-195.

Colpo E, Vilanova CD, Brenner Reetz LG, Medeiros Frescura Duarte MM, Farias IL, Irineu Muller E, . . . da Rocha JB. A single consumption of high amounts of the Brazil nuts improves lipid profile of healthy volunteers. Journal of nutrition and metabolism.2013;2013:653185.

Cordina-Duverger E, Truong T, Anger A, Sanchez M, Arveux P, Kerbrat P, Guenel P. Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France. BMC cancer.Sep 29 2016;16(1):761.

Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, . . . Hershman DL. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer prevention research (Philadelphia, Pa.).Sep 2012;5(9):1144-1154.

Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, . . . Hershman DL. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. Journal of human nutrition and dietetics: the official journal of the British Dietetic Association.Jun 2015;28(3):272-282.

Cropper C, Woodson A, Arun B, Barcenas C, Litton J, Noblin S, . . . Daniels M. Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer. Journal of the National Comprehensive Cancer Network: JNCCN.Jun 2017;15(6):797-803.

Curigliano G, Criscitiello C. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology.Aug 10 2017;35(23):2600-2603.

Cutuli B, De Lafontan B, Kirova Y, Auvray H, Tallet A, Avigdor S, . . . Delva C. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Radiation oncology (London, England).May 6 2015;10:110.

Dalasanur Nagaprashantha L, Adhikari R, Singhal J, Chikara S, Awasthi S, Horne D, Singhal SS. Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer. International journal of cancer. Journal international du cancer.Feb 15 2018;142(4):658-670.

Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutrition and cancer.2004;50(2):161-167.

Dandawate PR, Subramaniam D, Jensen RA, Anant S. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Seminars in cancer biology.Oct 2016;40-41:192-208.

Davidson N. Breast cancer and benign breast disorders. In: Goldman L, Schafer AI, eds. Goldman-Cecil medicine. Philadelphia, PA: Elsevier/Saunders; 2016.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, . . . for the Adjuvant Tamoxifen: Longer Against Shorter Collaborative G. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet.2013;381(9869):805-816.

Davies G, Lobanova L, Dawicki W, Groot G, Gordon JR, Bowen M, . . . Arnason T. Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer. PloS one.2017;12(12):e0187191.

de Groot AF, Appelman-Dijkstra NM, van der Burg SH, Kroep JR. The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review. Cancer treatment reviews.Nov 2 2017;62:18-28.

de Groot AF, Kuijpers CJ, Kroep JR. CDK4/6 inhibition in early and metastatic breast cancer: A review. Cancer treatment reviews.Nov 2017;60:130-138.

de Jesus Guirro RR, Oliveira Lima Leite Vaz MM, das Neves LMS, Dibai-Filho AV, Carrara HHA, de Oliveira Guirro EC. Accuracy and Reliability of Infrared Thermography in Assessment of the Breasts of Women Affected by Cancer. Journal of medical systems.May 2017;41(5):87.

DeBono NL, Robinson WR, Lund JL, Tse CK, Moorman PG, Olshan AF, Troester MA. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study. Journal of women's health (2002).Jun 01 2017.

DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, Lazzeroni M, . . . Pruneri G. Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial. Cancer prevention research (Philadelphia, Pa.).Oct 2015;8(10):888-894.

Deng G, Lin H, Seidman A, Fornier M, D'Andrea G, Wesa K, . . . Cassileth B. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. Journal of cancer research and clinical oncology.Sep 2009;135(9):1215-1221.

Deng S, Lin Z, Li W. Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment. Current medicinal chemistry.2017;24(23):2505-2527.

Deng X, Wu H, Gao F, Su Y, Li Q, Liu S, Cai J. Brachytherapy in the treatment of breast cancer. Int J Clin Oncol.Aug 2017;22(4):641-650.

Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV, . . . Ramesh A. Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective. Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.Oct 2011;29(4):324-357.

Dion L, Racin A, Brousse S, Beltjens F, Cauchois A, Leveque J, . . . Lavoue V. Atypical epithelial hyperplasia of the breast: state of the art. Expert review of anticancer therapy.Sep 2016;16(9):943-953.

Dixon JM. Screening for breast cancer. BMJ (Clinical research ed.).Mar 4 2006;332(7540):499-500.

Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, Gerald WL. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene.Jun 29 2006;25(28):3994-4008.

Doi T, Shitara K, Naito Y, Shimomura A, Fujiwara Y, Yonemori K, . . . Tamura K. Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study. The Lancet. Oncology.Oct 13 2017.

Domchek SM. Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions. Cancer Discov.Sep 2017;7(9):937-939.

Dominick SA, Madlensky L, Natarajan L, Pierce JP. Risk factors associated with breast cancer-related lymphedema in the WHEL Study. Journal of cancer survivorship: research and practice.Mar 2013;7(1):115-123.

Drukker CA, Bueno-de-Mesquita JM, Retel VP, van Harten WH, van Tinteren H, Wesseling J, . . . Linn SC. A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study. International journal of cancer. Journal international du cancer.Aug 15 2013;133(4):929-936.

Du G, Lin H, Wang M, Zhang S, Wu X, Lu L, . . . Yu L. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1alpha in tumor and normal cells. Cancer chemotherapy and pharmacology.Jan 2010;65(2):277-287.

Dubsky P, Brase JC, Jakesz R, Rudas M, Singer CF, Greil R, . . . Filipits M. The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients. British journal of cancer.Dec 10 2013;109(12):2959-2964.

Duffy MJ, Harbeck N, Nap M, Molina R, Nicolini A, Senkus E, Cardoso F. Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). European journal of cancer (Oxford, England: 1990). Apr 2017;75:284-298.

Dziaman T, Huzarski T, Gackowski D, Rozalski R, Siomek A, Szpila A, . . . Olinski R. Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.Nov 2009;18(11):2923-2928.

EBCTCG. Early Breast Cancer Trialists’ Collaborative Group. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet.Oct 3 2015;386(10001):1341-1352.

ECOG ACRIN Cancer Research Group. TMIST Breast Cancer Screening Trial. Copyright 2017. Accessed 2/13/2018.

Egger SJ, Willson ML, Morgan J, Walker HS, Carrick S, Ghersi D, Wilcken N. Platinum-containing regimens for metastatic breast cancer. The Cochrane database of systematic reviews.Jun 23 2017;6:Cd003374.

Eisemann BS, Spiegel AJ. Risk-Reducing Mastectomy and Breast Reconstruction: Indications and Evidence for Current Management Strategies. Clinics in plastic surgery.Jan 2018;45(1):129-136.

Eliassen AH, Liao X, Rosner B, Tamimi RM, Tworoger SS, Hankinson SE. Plasma carotenoids and risk of breast cancer over 20 y of follow-up. The American journal of clinical nutrition.Jun 2015;101(6):1197-1205.

Eliza WL, Fai CK, Chung LP. Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent patents on inflammation & allergy drug discovery.Jan 2012;6(1):78-87.

Erel S, Thull DL, Soran A. Partner and Localizer of BRCA-2 (PALB-2) Mutation Analysis Is Rapidly Being Adopted into Clinical Practice. The journal of breast health.Oct 2014;10(4):189.

Esposito E, Di Micco R, Gentilini OD. Sentinel node biopsy in early breast cancer. A review on recent and ongoing randomized trials. Breast (Edinburgh, Scotland). Dec 2017;36:14-19.

Ettl J, Harbeck N. The safety and efficacy of palbociclib in the treatment of metastatic breast cancer. Expert review of anticancer therapy.Aug 2017;17(8):661-668.

Fabian CJ, Kimler BF, Hursting SD. Omega-3 fatty acids for breast cancer prevention and survivorship. Breast cancer research: BCR.May 4 2015;17:62.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Petroff BK, Khan QJ, . . . Johnson KA. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer prevention research (Philadelphia, Pa.).Oct 2010;3(10):1342-1350.

Fan W, Chang J, Fu P. Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies. Future medicinal chemistry.Aug 2015;7(12):1511-1519.

Fanakidou I, Zyga S, Alikari V, Tsironi M, Stathoulis J, Theofilou P. Mental health, loneliness, and illness perception outcomes in quality of life among young breast cancer patients after mastectomy: the role of breast reconstruction. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation.Nov 08 2017.

Farshid G, Edwards S, Kollias J, Gill PG. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center. Mod Pathol.Nov 03 2017.

Fiorentino A, Mazzola R, Ricchetti F, Giaj Levra N, Fersino S, Naccarato S, . . . Alongi F. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity. Cancer radiotherapie: journal de la Societe francaise de radiotherapie oncologique.Aug 2015;19(5):289-294.

Flobbe K, Bosch AM, Kessels AG, Beets GL, Nelemans PJ, von Meyenfeldt MF, van Engelshoven JM. The additional diagnostic value of ultrasonography in the diagnosis of breast cancer. Archives of internal medicine.May 26 2003;163(10):1194-1199.

Flowers CI, O'Donoghue C, Moore D, Goss A, Kim D, Kim JH, . . . Esserman LJ. Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat.Jun 2013;139(3):769-777.

Foglietta J, Inno A, de Iuliis F, Sini V, Duranti S, Turazza M, . . . Gori S. Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients. Clinical breast cancer. Feb 2017;17(1):11-17.

Folkers K. Relevance of the biosynthesis of coenzyme Q10 and of the four bases of DNA as a rationale for the molecular causes of cancer and a therapy. Biochemical and biophysical research communications.Jul 16 1996;224(2):358-361.

Forcados GE, James DB, Sallau AB, Muhammad A, Mabeta P. Oxidative Stress and Carcinogenesis: Potential of Phytochemicals in Breast Cancer Therapy. Nutrition and cancer.Apr 2017;69(3):365-374.

Fowler ME, Akinyemiju TF. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. International journal of cancer. Journal international du cancer. Dec 01 2017;141(11):2215-2227.

Fox P, Darley A, Furlong E, Miaskowski C, Patiraki E, Armes J, . . . Maguire R. The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas: A scoping review. European journal of oncology nursing: the official journal of European Oncology Nursing Society.Feb 2017;26:63-82.

Francis PA, Regan MM, Fleming GF, Lang I, Ciruelos E, Bellet M, . . . Gelber RD. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. Jan 29 2015;372(5):436-446.

Frykberg ER. Lobular Carcinoma In Situ of the Breast. The breast journal.Sep 1999;5(5):296-303.

Gammon MD, Sagiv SK, Eng SM, Shantakumar S, Gaudet MM, Teitelbaum SL, . . . Santella RM. Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Archives of environmental health.Dec 2004;59(12):640-649.

Gapstur SM, Anderson RL, Campbell PT, Jacobs EJ, Hartman TJ, Hildebrand JS, . . . McCullough ML. Associations of Coffee Drinking and Cancer Mortality in the Cancer Prevention Study-II. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Oct 2017;26(10):1477-1486.

Garduno-Ramon MA, Vega-Mancilla SG, Morales-Henandez LA, Osornio-Rios RA. Supportive Noninvasive Tool for the Diagnosis of Breast Cancer Using a Thermographic Camera as Sensor. Sensors (Basel, Switzerland).Mar 3 2017;17(3).

Garner WL, Minton, JP, James AG, Hoffman CC. Human breast cancer and impaired NK cell function. Journal of Surgical Oncology. 24(1):64-66.

Geenen JJJ, Linn SC, Beijnen JH, Schellens JHM. PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer. Clinical pharmacokinetics.Oct 23 2017.

Gennaro G, Bernardi D, Houssami N. Radiation dose with digital breast tomosynthesis compared to digital mammography: per-view analysis. European radiology.Aug 17 2017.

Gentzler R, Hall R, Kunk PR, Gaughan E, Dillon P, Slingluff CL, Jr., Rahma OE. Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors. Immunotherapy.May 2016;8(5):583-600.

Ghoreishi Z, Esfahani A, Djazayeri A, Djalali M, Golestan B, Ayromlou H, . . . Darabi M. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC cancer.Aug 15 2012;12:355.

Gianfredi V, Vannini S, Moretti M, Villarini M, Bragazzi NL, Izzotti A, Nucci D. Sulforaphane and Epigallocatechin Gallate Restore Estrogen Receptor Expression by Modulating Epigenetic Events in the Breast Cancer Cell Line MDA-MB-231: A Systematic Review and Meta-Analysis. Journal of nutrigenetics and nutrigenomics.2017;10(3-4):126-135.

Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, . . . Myers ER. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.Nov 2013;22(11):1931-1943.

Giese-Davis J, Bliss-Isberg C, Wittenberg L, White J, Star P, Zhong L, . . . Spiegel D. Peer-counseling for women newly diagnosed with breast cancer: A randomized community/research collaboration trial. Cancer. Aug 01 2016;122(15):2408-2417.

Giess CS, Pourjabbar S, Ip IK, Lacson R, Alper E, Khorasani R. Comparing Diagnostic Performance of Digital Breast Tomosynthesis and Full-Field Digital Mammography in a Hybrid Screening Environment. AJR. American journal of roentgenology.Oct 2017;209(4):929-934.

Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, . . . Nielsen TO. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. Ann Oncol.Feb 2014;25(2):339-345.

Godskesen T, Hansson MG, Nygren P, Nordin K, Kihlbom U. Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials. European journal of cancer care. 2015;24(1):133-141.

Goetz MP, Suman VJ, Reid JM, Northfelt DW, Mahr MA, Ralya AT, . . . Ingle JN. First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology.Oct 20 2017;35(30):3391-3400.

Gourd E. Thermography should not be used in breast cancer screening. The Lancet. Oncology. Dec 2017;18(12):e713.

Gray RJ, Pockaj BA, Garvey E, Blair S. Intraoperative Margin Management in Breast-Conserving Surgery: A Systematic Review of the Literature. Annals of surgical oncology.Jan 05 2017.

Greeley CF, Frost AR. Cytologic features of ductal and lobular carcinoma in fine needle aspirates of the breast. Acta cytologica.Mar-Apr 1997;41(2):333-340.

Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat.Jun 2009;115(3):437-452.

Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, Weltzien E, . . . Caan BJ. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer.Apr 15 2012;118(8):2048-2058.

Grossman J, Ma C, Aft R. Neoadjuvant Endocrine Therapy: Who Benefits Most? Surgical oncology clinics of North America.Jan 2018;27(1):121-140.

Grossmann ME, Mizuno NK, Schuster T, Cleary MP. Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation. International journal of oncology.Feb 2010;36(2):421-426.

Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annu Rev Nutr.Aug 21 2017;37:131-156.

Gu J, Groot G, Holtslander L, Engler-Stringer R. Understanding Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early-Stage Breast Cancer. Clinical Medicine Insights. Oncology.2017;11:1179554917691266.

Gu L, House SE, Prior RL, Fang N, Ronis MJ, Clarkson TB, . . . Badger TM. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. The Journal of nutrition.May 2006;136(5):1215-1221.

Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, . . . Traina TA. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clinical cancer research: an official journal of the American Association for Cancer Research.Oct 01 2013;19(19):5505-5512.

Guggenheim AG, Wright KM, Zwickey HL. Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology. Integrative medicine (Encinitas, Calif.).Feb 2014;13(1):32-44.

Guha N, Kwan ML, Quesenberry CP, Jr., Weltzien EK, Castillo AL, Caan BJ. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. Nov 2009;118(2):395-405.

Guo R, Lu G, Qin B, Fei B. Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review. Ultrasound in medicine & biology. Oct 26 2017.

Gyorffy B, Hatzis C, Sanft T, Hofstatter E, Aktas B, Pusztai L. Multigene prognostic tests in breast cancer: past, present, future. Breast cancer research: BCR.Jan 27 2015;17:11.

Ha TY. The role of regulatory T cells in cancer. Immune network.Dec 2009;9(6):209-235.

Hadad SM, Coates P, Jordan LB, Dowling RJ, Chang MC, Done SJ, . . . Thompson AM. Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial. Breast Cancer Res Treat.Feb 2015;150(1):149-155.

Hadji P, Aapro MS, Body JJ, Gnant M, Brandi ML, Reginster JY, . . . Coleman RE. Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. Journal of bone oncology.Jun 2017;7:1-12.

Haller H, Winkler MM, Klose P, Dobos G, Kummel S, Cramer H. Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis. Acta oncologica (Stockholm, Sweden).Dec 2017;56(12):1665-1676.

Hamelinck VC, Bastiaannet E, Pieterse AH, Merkus JWS, Jannink I, den Hoed IDM, . . . Stiggelbout AM. A prospective comparison of younger and older patients' preferences for breast-conserving surgery versus mastectomy in early breast cancer. Journal of geriatric oncology.Sep 11 2017.

Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, . . . Wolff AC. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Archives of pathology & laboratory medicine.Jul 2010;134(7):e48-72.

Hansen J. Night Shift Work and Risk of Breast Cancer. Current environmental health reports.Sep 2017;4(3):325-339.

Hansen MV, Andersen LT, Madsen MT, Hageman I, Rasmussen LS, Bokmand S, . . . Gogenur I. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Breast Cancer Res Treat. Jun 2014;145(3):683-695.

Hardefeldt PJ, Penninkilampi R, Edirimanne S, Eslick GD. Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies. Clinical breast cancer.Oct 17 2017.

Harris HR, Bergkvist L, Wolk A. Selenium intake and breast cancer mortality in a cohort of Swedish women. Breast Cancer Res Treat.Aug 2012;134(3):1269-1277.

Harris HR, Orsini N, Wolk A. Vitamin C and survival among women with breast cancer: a meta-analysis. European journal of cancer (Oxford, England: 1990).May 2014;50(7):1223-1231.

Harris LN, Bauer MR, Wiley JF, Hammen C, Krull JL, Crespi CM, . . . Stanton AL. Chronic and episodic stress predict physical symptom bother following breast cancer diagnosis. Journal of behavioral medicine.Dec 2017;40(6):875-885.

Harris LN, Ismaila N, McShane LM, Andre F, Collyar DE, Gonzalez-Angulo AM, . . . Hayes DF. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol.Apr 1 2016;34(10):1134-1150.

Harvie M, Howell A, Evans DG. Can diet and lifestyle prevent breast cancer: what is the evidence? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting. 2015:e66-73.

Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, . . . Rezaee R. Anticancer and apoptosisinducing effects of quercetin in vitro and in vivo. Oncology reports.Aug 2017;38(2):819-828.

Haukka J, Niskanen L, Auvinen A. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin. International journal of cancer. Journal international du cancer.Dec 15 2017;141(12):2437-2449.

He X, Sun L, Huo Y, Shao M, Ma C. A comparative study of 18F-FDG PET/CT and ultrasonography in the diagnosis of breast cancer and axillary lymph node metastasis. Q J Nucl Med Mol Imaging. Dec 2017;61(4):429-437.

Heindl A, Sestak I, Naidoo K, Cuzick J, Dowsett M, Yuan Y. Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer. J Natl Cancer Inst.Feb 01 2018;110(2).

Heitz AE, Baumgartner RN, Baumgartner KB, Boone SD. Healthy lifestyle impact on breast cancer-specific and all-cause mortality. Breast Cancer Res Treat.Aug 31 2017.

Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, . . . Koch T. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. International journal of cancer. Journal international du cancer.Sep 10 2004;111(4):611-616.

Henderson MC, Hollingsworth AB, Gordon K, Silver M, Mulpuri R, Letsios E, Reese DE. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer. PloS one.2016;11(8):e0157692.

Hill SM, Belancio VP, Dauchy RT, Xiang S, Brimer S, Mao L, . . . Blask DE. Melatonin: an inhibitor of breast cancer. Endocrine-related cancer.Jun 2015;22(3):R183-204.

Hilton HN, Clarke CL, Graham JD. Estrogen and progesterone signalling in the normal breast and its implications for cancer development. Molecular and cellular endocrinology.Aug 26 2017.

Holbrook A, Newel MS. Alternative screening for women with dense breasts: breast-specific gamma imaging (molecular breast imaging). AJR. American journal of roentgenology.Feb 2015;204(2):252-256.

Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst.Apr 28 2014;106(5).

Hu K, Callen DF, Li J, Zheng H. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies. Integrative cancer therapies. May 1 2017:1534735417712007.

Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, . . . Willett WC. Dual effects of weight and weight gain on breast cancer risk. JAMA.Nov 05 1997;278(17):1407-1411.

Huget JA. Suzanne Somers undergoes controversial breast reconstruction. The Washington Post (blog). 2012.

Hung CM, Liu LC, Ho CT, Lin YC, Way TD. Pterostilbene enhances TRAIL-induced apoptosis through the induction of death receptors and downregulation of cell survival proteins in TRAIL-resistance triple negative breast cancer cells. Journal of agricultural and food chemistry.Nov 22 2017.

Hutchins-Wiese HL, Picho K, Watkins BA, Li Y, Tannenbaum S, Claffey K, Kenny AM. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study. Nutrition and cancer.2014;66(1):68-76.

Inoue M, Tajima K, Mizutani M, Iwata H, Iwase T, Miura S, . . . Tominaga S. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer letters.Jun 26 2001;167(2):175-182.

Ip C, Dong Y. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer research.Mar-Apr 2001;21(2a):863-867.

Ito S, Kai Y, Masuda T, Tanaka F, Matsumoto T, Kamohara Y, . . . Mori M. Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer. Surgery today.Dec 2017;47(12):1500-1511.

Jacob L, Kostev K, Rathmann W, Kalder M. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes. Journal of diabetes and its complications.Aug 2016;30(6):1056-1059.

Jagtap DB, Thakur A, Deol A, Al-Kadhimi Z, Simon MS, Flaherty LE. Phase II trial evaluating HER2 targeted activated T cells in advanced HER2 low expressing breast cancer patients. J Clin Oncol.2014;32(15_suppl):3073.

Jameera Begam A, Jubie S, Nanjan MJ. Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review. Bioorganic chemistry.Apr 2017;71:257-274.

Jensen A, Geller BM, Gard CC, Miglioretti DL, Yankaskas B, Carney PA, . . . Lynge E. Performance of diagnostic mammography differs in the United States and Denmark. International journal of cancer. Journal international du cancer. Oct 15 2010;127(8):1905-1912.

Jeyabalan J, Aqil F, Munagala R, Annamalai L, Vadhanam MV, Gupta RC. Chemopreventive and therapeutic activity of dietary blueberry against estrogen-mediated breast cancer. Journal of agricultural and food chemistry.May 7 2014;62(18):3963-3971.

Jiang W, Wu Y, Jiang X. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecologic oncology.Jun 2013;129(3):620-629.

Jiang Y, Chang Y, Liu Y, Zhang M, Luo H, Hao C, . . . Zhang L. Overview of Ganoderma sinense polysaccharide-an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in China. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. Oct 19 2017;96:865-870.

Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. The Cochrane database of systematic reviews.Jun 13 2012(6):Cd007731.

John MECfCD, Communications S. AHRQ Comparative Effectiveness Reviews

Having a Breast Biopsy: A Review of the Research for Women and Their Families. Comparative Effectiveness Review Summary Guides for Consumers. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016.

Johns SA, Brown LF, Beck-Coon K, Talib TL, Monahan PO, Giesler RB, . . . Kroenke K. Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer.Oct 2016;24(10):4085-4096.

Jones JL. Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective. Breast cancer research: BCR.2006;8(2):204.

Jorgensen KJ, Gotzsche PC, Kalager M, Zahl PH. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Annals of internal medicine.Mar 7 2017;166(5):313-323.

Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis.Apr 2006;27(4):856-863.

Jung U, Zheng X, Yoon SO, Chung AS. Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Free radical biology & medicine.Aug 15 2001;31(4):479-489.

Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J, . . . Rohan TE. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.Sep 22 2017.

Kajla P, Sharma A, Sood DR. Flaxseed-a potential functional food source. Journal of food science and technology.Apr 2015;52(4):1857-1871.

Kanaya N, Adams L, Takasaki A, Chen S. Whole blueberry powder inhibits metastasis of triple negative breast cancer in a xenograft mouse model through modulation of inflammatory cytokines. Nutrition and cancer.2014;66(2):242-248.

Kapinova A, Stefanicka P, Kubatka P, Zubor P, Uramova S, Kello M, . . . Kruzliak P. Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.Dec 2017;96:1465-1477.

Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, . . . Fabian CJ. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial. Breast Cancer Res Treat.Nov 2017;166(2):491-500.

Khan QJ, Reddy PS, Kimler BF, Sharma P, Baxa SE, O'Dea AP, . . . Fabian CJ. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat.Jan 2010;119(1):111-118.

Khankari NK, Bradshaw PT, Steck SE, He K, Olshan AF, Shen J, . . . Gammon MD. Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York. Cancer.Mar 24 2015.

Khatami F, Aghayan HR, Sanaei M, Heshmat R, Tavangar SM, Larijani B. The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review. Acta medica Iranica.Mar 2017;55(3):175-193.

Khazaei Koohpar Z, Entezari M, Movafagh A, Hashemi M. Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene. Iranian journal of cancer prevention.May 2015;8(3):e2331.

Kim CS, Algan O. Radiation Therapy, Breast Cancer Early Stage. StatPearls. Treasure Island (FL): StatPearls Publishing, LLC.; 2017.

Kim G, Ison G, McKee AE, Zhang H, Tang S, Gwise T, . . . Pazdur R. FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy. Clinical cancer research: an official journal of the American Association for Cancer Research.Oct 01 2015;21(19):4257-4261.

Kim JH, Lee J, Jung SY, Kim J. Dietary Factors and Female Breast Cancer Risk: A Prospective Cohort Study. Nutrients. Dec 7 2017;9(12).

Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, . . . Lansky E. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast cancer research and treatment.Feb 2002;71(3):203-217.

Kim SH, Park HJ, Moon DO. Sulforaphane sensitizes human breast cancer cells to paclitaxel-induced apoptosis by downregulating the NF-kappaB signaling pathway. Oncology letters.Jun 2017;13(6):4427-4432.

Kindts I, Laenen A, Depuydt T, Weltens C. Tumour bed boost radiotherapy for women after breast-conserving surgery. The Cochrane database of systematic reviews.Nov 06 2017;11:Cd011987.

King L, O'Neill SC, Spellman E, Peshkin BN, Valdimarsdottir H, Willey S, . . . Schwartz MD. Intentions for bilateral mastectomy among newly diagnosed breast cancer patients. Journal of surgical oncology.Jun 2013;107(7):772-776.

Kiremidjian-Schumacher L, Roy M, Glickman R, Schneider K, Rothstein S, Cooper J, . . . Newman R. Selenium and immunocompetence in patients with head and neck cancer. Biological trace element research.Feb 2000;73(2):97-111.

Kirkham AA, Eves ND, Shave RE, Bland KA, Bovard J, Gelmon KA, . . . Campbell KL. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Res Treat.Nov 06 2017.

Klimberg VS, Rivere A. Ultrasound image-guided core biopsy of the breast. Chinese clinical oncology.Jun 2016;5(3):33.

Knauer M, Mook S, Rutgers EJ, Bender RA, Hauptmann M, van de Vijver MJ, . . . van 't Veer LJ. The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat.Apr 2010;120(3):655-661.

Knuttel FM, Menezes GL, van Diest PJ, Witkamp AJ, van den Bosch MA, Verkooijen HM. Meta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen. The British journal of surgery.May 2016;103(6):644-655.

Ko KP, Ma SH, Yang JJ, Hwang Y, Ahn C, Cho YM, . . . Park SK. Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial. Breast Cancer Res Treat.Sep 2015;153(2):361-370.

Kole AJ, Kole L, Moran MS. Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast cancer (Dove Medical Press).2017;9:313-323.

Kono M, Fujii T, Lim B, Karuturi MS, Tripathy D, Ueno NT. Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review. JAMA Oncol.Sep 01 2017;3(9):1266-1273.

Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA. Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast cancer research: BCR.2010;12(6):R106.

Kotsopoulos J, Zhang S, Akbari M, Salmena L, Llacuachaqui M, Zeligs M, . . . Narod SA. BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane. British journal of cancer.Sep 23 2014;111(7):1269-1274.

Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M. Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib. OncoTargets and therapy.2017;10:3363-3372.

Kowalska E, Narod SA, Huzarski T, Zajaczek S, Huzarska J, Gorski B, Lubinski J. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.May 2005;14(5):1302-1306.

Kozick Z, Hashmi A, Dove J, Hunsinger M, Arora T, Wild J, . . . Blansfield J. Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment. American journal of surgery.Jun 09 2017.

Kristensen B, Ejlertsen B, Jensen MB, Mouridsen HT. The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study. Acta oncologica (Stockholm, Sweden).Nov 23 2017:1-5.

Kroenke CH, Fung TT, Hu FB, Holmes MD. Dietary patterns and survival after breast cancer diagnosis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Dec 20 2005;23(36):9295-9303.

Kroenke CH, Kwan ML, Sweeney C, Castillo A, Caan BJ. High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. Journal of the National Cancer Institute.May 1 2013;105(9):616-623.

Kubota Y. Tumor angiogenesis and anti-angiogenic therapy. The Keio journal of medicine.2012;61(2):47-56.

Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, . . . Olsson H. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA.Jun 20 2017;317(23):2402-2416.

Kwapisz D. Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib. Breast Cancer Res Treat.Nov 2017;166(1):41-54.

Laloze J, Varin A, Bertheuil N, Grolleau JL, Vaysse C, Chaput B. Cell-assisted lipotransfer: Current concepts. Annales de chirurgie plastique et esthetique.Dec 2017;62(6):609-616.

Lamberti MJ, Vittar NB, Rivarola VA. Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexity. World journal of clinical oncology.Dec 10 2014;5(5):901-907.

Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, . . . Bonanni B. A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer. Cancer prevention research (Philadelphia, Pa.).Jan 2016;9(1):89-95.

Lee CI, Chen LE, Elmore JG. Risk-based Breast Cancer Screening: Implications of Breast Density. The Medical clinics of North America.Jul 2017;101(4):725-741.

Lee RJ, Vallow LA, McLaughlin SA, Tzou KS, Hines SL, Peterson JL. Ductal carcinoma in situ of the breast. International journal of surgical oncology.2012;2012:123549.

Lee SJ, Trikha S, Moy L, Baron P, diFlorio RM, Green ED, . . . Newell MS. ACR Appropriateness Criteria(R) Evaluation of Nipple Discharge. Journal of the American College of Radiology: JACR. May 2017;14(5s):S138-s153.

Leischner C, Burkard M, Pfeiffer MM, Lauer UM, Busch C, Venturelli S. Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment. Nutr J.May 4 2016;15(1):47.

Li J, Zou L, Chen W, Zhu B, Shen N, Ke J, . . . Miao X. Dietary mushroom intake may reduce the risk of breast cancer: evidence from a meta-analysis of observational studies. PloS one.2014;9(4):e93437.

Li Y, Li S, Meng X, Gan RY, Zhang JJ, Li HB. Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients.Jul 08 2017;9(7).

Licznerska BE, Szaefer H, Murias M, Bartoszek A, Baer-Dubowska W. Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3'-diindolylmethene in human breast epithelial cell lines. European journal of nutrition. Aug 2013;52(5):1483-1492.

Lieberman A, Curtis L. In Defense of Progesterone: A Review of the Literature. Alternative therapies in health and medicine.Oct 21 2017.

Limon-Miro AT, Lopez-Teros V, Astiazaran-Garcia H. Dietary Guidelines for Breast Cancer Patients: A Critical Review. Adv Nutr.Jul 2017;8(4):613-623.

Lin Z, Zhang Z, Jiang X, Kou X, Bao Y, Liu H, . . . Yang Y. Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells. Oncotarget.Mar 14 2017;8(11):17833-17848.

Link LB, Canchola AJ, Bernstein L, Clarke CA, Stram DO, Ursin G, Horn-Ross PL. Dietary patterns and breast cancer risk in the California Teachers Study cohort. The American journal of clinical nutrition. Dec 2013;98(6):1524-1532.

Lippman M, Monaco ME, Bolan G. Effects of Estrone, Estradiol, and Estriol on Hormone-responsive Human Breast Cancer in Long-Term Tissue Culture. Cancer research.1977;37(6):1901-1907.

Lissoni P, Ardizzoia A, Barni S, Paolorossi F, Tancini G, Meregalli S, . . . Braczowski R. A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients. Oncology reports.Sep 1995;2(5):871-873.

Lissoni P, Barni S, Meregalli S, Fossati V, Cazzaniga M, Esposti D, Tancini G. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. British journal of cancer. Apr 1995;71(4):854-856.

Liu B, Yi Z, Guan X, Zeng YX, Ma F. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis. Breast Cancer Res Treat.Jul 2017;164(1):1-11.

Liu X, Lv K. Cruciferous vegetables intake is inversely associated with risk of breast cancer: a meta-analysis. Breast (Edinburgh, Scotland).Jun 2013;22(3):309-313.

Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teule A, . . . Grana B. SEOM clinical guidelines in Hereditary Breast and ovarian cancer. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.Dec 2015;17(12):956-961.

Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy reviews.Jul 2010;4(8):118-126.

Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochemical and biophysical research communications.Mar 30 1994;199(3):1504-1508.

Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochemical and biophysical research communications.Jul 06 1995;212(1):172-177.

Lopes CM, Dourado A, Oliveira R. Phytotherapy and Nutritional Supplements on Breast Cancer. Biomed Res Int.2017;2017:7207983.

Lourenco AP, Benson KL, Henderson MC, Silver M, Letsios E, Tran Q, . . . Reese DE. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years. Clinical breast cancer.Nov 2017;17(7):516-525.e516.

Lousberg L, Jerusalem G. Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer. Breast cancer: basic and clinical research.2016;10:239-252.

Lowcock EC, Cotterchio M, Boucher BA. Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. Cancer Causes Control. Apr 2013;24(4):813-816.

Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B, Cebula-Obrzut B, Smolewski P, Fabianowska-Majewska K. Sulforaphane Alone and in Combination with Clofarabine Epigenetically Regulates the Expression of DNA Methylation-Silenced Tumour Suppressor Genes in Human Breast Cancer Cells. Journal of nutrigenetics and nutrigenomics.2015;8(2):91-101.

Lubinski J, Marciniak W, Muszynska M, Huzarski T, Gronwald J, Cybulski C, . . . Narod SA. Serum selenium levels predict survival after breast cancer. Breast Cancer Res Treat.Oct 17 2017.

Lum LG, Thakur A, Al-Kadhimi Z, Colvin GA, Cummings FJ, Legare RD, . . . Rathore R. Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial. Clinical cancer research: an official journal of the American Association for Cancer Research.May 15 2015;21(10):2305-2314.

Lunoe K, Gabel-Jensen C, Sturup S, Andresen L, Skov S, Gammelgaard B. Investigation of the selenium metabolism in cancer cell lines. Metallomics.Feb 2011;3(2):162-168.

Lyi SM, Heller LI, Rutzke M, Welch RM, Kochian LV, Li L. Molecular and biochemical characterization of the selenocysteine Se-methyltransferase gene and Se-methylselenocysteine synthesis in broccoli. Plant physiology.May 2005;138(1):409-420.

Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, . . . Ellis MJ. NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer. Clinical cancer research: an official journal of the American Association for Cancer Research.Aug 01 2017;23(15):4055-4065.

Madsen MT, Hansen MV, Andersen LT, Hageman I, Rasmussen LS, Bokmand S, . . . Gogenur I. Effect of Melatonin on Sleep in the Perioperative Period after Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine.Feb 2016;12(2):225-233.

Maeding N, Verwanger T, Krammer B. Boosting Tumor-Specific Immunity Using PDT. Cancers.Oct 06 2016;8(10).

Mafuvadze B, Liang Y, Besch-Williford C, Zhang X, Hyder SM. Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors. Hormones & cancer.Aug 2012;3(4):160-171.

Mahmoodi N, Motamed N, Paylakhi SH, N OM. Comparing the Effect of Silybin and Silybin Advanced on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation. Iranian journal of pharmaceutical research: IJPR.Spring 2015;14(2):521-530.

Maiani G, Caston MJ, Catasta G, Toti E, Cambrodon IG, Bysted A, . . . Schlemmer U. Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res.Sep 2009;53 Suppl 2:S194-218.

Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED, . . . Newell MS. ACR Appropriateness Criteria(R) Breast Cancer Screening. Journal of the American College of Radiology: JACR.Nov 2017;14(11s):S383-s390.

Mali AV, Joshi AA, Hegde MV, Kadam Sh S. Enterolactone Suppresses Proliferation, Migration and Metastasis of MDA-MB-231 Breast Cancer Cells Through Inhibition of uPA Induced Plasmin Activation and MMPs-Mediated ECM Remodeling. Asian Pacific journal of cancer prevention: APJCP.Apr 01 2017;18(4):905-915.

Mall S, Lewis S, Brennan P, Noakes J, Mello-Thoms C. The role of digital breast tomosynthesis in the breast assessment clinic: a review. Journal of medical radiation sciences.Sep 2017;64(3):203-211.

Manchanda R, Patel S, Antoniou AC, Levy-Lahad E, Turnbull C, Evans DG, . . . Legood R. Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry. American journal of obstetrics and gynecology.Nov 2017;217(5):578.e571-578.e512.

Mandal A, Bishayee A. Mechanism of Breast Cancer Preventive Action of Pomegranate: Disruption of Estrogen Receptor and Wnt/beta-Catenin Signaling Pathways. Molecules (Basel, Switzerland).Dec 12 2015;20(12):22315-22328.

Mannal P, McDonald D, McFadden D. Pterostilbene and tamoxifen show an additive effect against breast cancer in vitro. American journal of surgery.Nov 2010;200(5):577-580.

Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, . . . Wallace RB. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA.Oct 2 2013;310(13):1353-1368.

Mansour M, Teo ZL, Luen SJ, Loi S. Advancing Immunotherapy in Metastatic Breast Cancer. Current treatment options in oncology.Jun 2017;18(6):35.

Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis. International journal of cancer. Journal international du cancer.Sep 15 2016;139(6):1281-1288.

Marconett CN, Singhal AK, Sundar SN, Firestone GL. Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells. Molecular and cellular endocrinology.Nov 5 2012;363(1-2):74-84.

Marmorston J, Crowley LG, Myers SM, Stern E, Hopkins CE. Urinary excretion of estrone estradiol and estriol by patients with breast cancer and benign breast disease. American journal of obstetrics and gynecology.1965;92(4):460-467.

Maskarinec G, Jacobs S, Park SY, Haiman CA, Setiawan VW, Wilkens LR, Le Marchand L. Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.Jun 2017;26(6):854-861.

Mason JK, Thompson LU. Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer? Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. Jun 2014;39(6):663-678.

Mayo Clinic. Symptoms: Breast lumps. 1/11/2018. Accessed 2/8/2018.

McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, . . . Freudenheim JL. Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat.Jul 2010;122(1):229-235.

McCarthy CM, Hamill JB, Kim HM, Qi J, Wilkins E, Pusic AL. Impact of Bilateral Prophylactic Mastectomy and Immediate Reconstruction on Health-Related Quality of Life in Women at High Risk for Breast Carcinoma: Results of the Mastectomy Reconstruction Outcomes Consortium Study. Annals of surgical oncology.Sep 2017;24(9):2502-2508.

McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.Jun 2006;15(6):1159-1169.

McGowan MM, Eisenberg BL, Lewis LD, Froehlich HM, Wells WA, Eastman A, . . . Kinlaw WB. A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue. Breast cancer research and treatment. Feb 2013;138(1):175-183.

McLaughlin SA, Bagaria S, Gibson T, Arnold M, Diehl N, Crook J, . . . Nguyen J. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. Journal of the American College of Surgeons.Mar 2013;216(3):380-389; quiz 511-383.

McNamara KM, Guestini F, Sakurai M, Kikuchi K, Sasano H. How far have we come in terms of estrogens in breast cancer? [Review]. Endocrine journal.May 31 2016;63(5):413-424.

Mehrgou A, Akouchekian M. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Medical journal of the Islamic Republic of Iran.2016;30:369.

Mehrotra P, Townend A, Lunt L. Incidental breast cancers identified in the one-stop symptomatic breast clinic. Journal of breast cancer.Mar 2011;14(1):28-32.

Mehta R, Lansky EP. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP).Aug 2004;13(4):345-348.

Mei Z, Liang M, Li L, Zhang Y, Wang Q, Yang W. Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals. International journal of cancer. Journal international du cancer.Mar 01 2017;140(5):1068-1081.

Melamed M, Castano E, Notides AC, Sasson S. Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol. Molecular endocrinology (Baltimore, Md.).Nov 1997;11(12):1868-1878.

Mello J, Bittelbrunn FP, Rockenbach M, May GG, Vedolin LM, Kruger MS, . . . Arruda BS. Breast cancer mammographic diagnosis performance in a public health institution: a retrospective cohort study. Insights into imaging.Oct 04 2017.

Messina M. Impact of Soy Foods on the Development of Breast Cancer and the Prognosis of Breast Cancer Patients. Forschende Komplementarmedizin (2006).2016;23(2):75-80.

Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care.Jun 2003;26(6):1752-1758.

Mijwel S, Backman M, Bolam KA, Jervaeus A, Sundberg CJ, Margolin S, . . . Wengstrom Y. Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial. Breast Cancer Res Treat.Nov 14 2017.

Milczarek M, Wiktorska K, Mielczarek L, Koronkiewicz M, Dabrowska A, Lubelska K, . . . Chilmonczyk Z. Autophagic cell death and premature senescence: New mechanism of 5-fluorouracil and sulforaphane synergistic anticancer effect in MDA-MB-231 triple negative breast cancer cell line. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association.Nov 2 2017;111:1-8.

Mina A, Yoder R, Sharma P. Targeting the androgen receptor in triple-negative breast cancer: current perspectives. OncoTargets and therapy.2017;10:4675-4685.

Mislick K, Schonfeld W, Bodnar C, Tong KB. Cost-effectiveness analysis of Mammostrat(R) compared with Oncotype DX(R) to inform the treatment of breast cancer. ClinicoEconomics and outcomes research: CEOR.2014;6:37-47.

Mittendorf EA, Ardavanis A, Litton JK, Shumway NM, Hale DF, Murray JL, . . . Peoples GE. Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence. Oncotarget.Oct 04 2016;7(40):66192-66201.

Molavi O, Narimani F, Asiaee F, Sharifi S, Tarhriz V, Shayanfar A, . . . Lai R. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy. Pharmaceutical biology.Dec 2017;55(1):729-739.

Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, . . . Morrow M. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. International journal of radiation oncology, biology, physics.Mar 01 2014;88(3):553-564.

Morch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard O. Contemporary Hormonal Contraception and the Risk of Breast Cancer. The New England journal of medicine.Dec 7 2017;377(23):2228-2239.

Morrison SA, Hill SL, Rogers GS, Graham RA. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer. The Journal of surgical research. Dec 2014;192(2):235-241.

Morrow DM, Fitzsimmons PE, Chopra M, McGlynn H. Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mutation research.Sep 1 2001;480-481:269-276.

Morrow M. The evaluation of common breast problems. American family physician.Apr 15 2000;61(8):2371-2378, 2385.

Moyer VA. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med.Feb 18 2014;160(4):271-281.

Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P, . . . Das T. Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/beta-catenin negative feedback loop. Stem cell research & therapy. Oct 14 2014;5(5):116.

Murphy BD, Kerrebijn I, Farhadi J, Masia J, Hofer SOP. Indications and Controversies for Abdominally-Based Complete Autologous Tissue Breast Reconstruction. Clinics in plastic surgery.Jan 2018;45(1):83-91.

Nanda R, Chow LQ, Dees EC, Berger R, Gupta S, Geva R, . . . Buisseret L. Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Jul 20 2016;34(21):2460-2467.

NCCIH. National Center for Complementary and Integrative Health. Coenzyme Q10 (CoQ10): In Depth. Last updated 3/2015. Accessed 2/13/2018.

NCCN. National Comprehensive Cancer Network. NCCN Guidelines for Patients: Breast Cancer Metastatic Stage IV. Version 2. 2017a. Accessed December 20, 2017.

NCCN. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. 2017b. Accessed 2/8/2018.

NCCN. National Comprehensive Cancer Network. NCCN Guidelines for Patients: Breast Cancer Early-Stage Stages I and II. Version 1. 2016. Accessed 2/8/2018.

NCI. National Cancer Institute. BRCA Mutations: Cancer Risk and Genetic Testing. 1/30/2018. Accessed 2/13/2018.

NCI. National Cancer Institute. Lymphedema (PDQ)–Patient Version. Last updated 5/29/2015. Accessed 2/13/2018.

NCI. National Cancer Institute. Photodynamic Therapy for Cancer. 9/6/2011. Accessed 2/13/2018.

Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, Mac Bride MB, Dilaveri CA, . . . Visscher DW. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clinic proceedings.Apr 2014;89(4):536-547.

Neal L, Tortorelli CL, Nassar A. Clinician's guide to imaging and pathologic findings in benign breast disease. Mayo Clinic proceedings.Mar 2010;85(3):274-279.

Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, . . . Shu XO. Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Feb 2011;20(2):262-271.

Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, Kwan ML, . . . Shu XO. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. The American journal of clinical nutrition.Jul 2012;96(1):123-132.

Nelson HD, Walker M, Zakher B, Mitchell J. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: Systematic Review to Update the 2002 and 2005 U.S. Preventive Services Task Force Recommendations. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012.

Nelson JA, Disa JJ. Breast Reconstruction and Radiation Therapy: An Update. Plastic and reconstructive surgery. Nov 2017;140(5S Advances in Breast Reconstruction):60s-68s.

Nguyen LT, Lee YH, Sharma AR, Park JB, Jagga S, Sharma G, . . . Nam JS. Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity. The Korean journal of physiology & pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology. Mar 2017;21(2):205-213.

Nicholson A. Diet and the prevention and treatment of breast cancer. Altern Ther Health Med.Nov 1996;2(6):32-38.

Nickoloff JA, Jones D, Lee SH, Williamson EA, Hromas R. Drugging the Cancers Addicted to DNA Repair. J Natl Cancer Inst.Nov 01 2017;109(11).

Nicolini A, Ferrari P, Duffy MJ. Prognostic and predictive biomarkers in breast cancer: Past, present and future. Semin Cancer Biol.Sep 04 2017.

Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Screening for Breast Cancer. Radiologic clinics of North America.Nov 2017;55(6):1145-1162.

Nishijima TF, Suzuki M, Muss HB. A comparison of toxicity profiles between the lower and standard dose capecitabine in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat.Apr 2016;156(2):227-236.

Nofech-Mozes S, Vella ET, Dhesy-Thind S, Hagerty KL, Mangu PB, Temin S, Hanna WM. Systematic review on hormone receptor testing in breast cancer. Applied immunohistochemistry & molecular morphology: AIMM.May 2012;20(3):214-263.

Nourmoussavi M, Pansegrau G, Popesku J, Hammond GL, Kwon JS, Carey MS. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause. Cancer treatment reviews.Apr 2017;55:26-35.

Novaes MR, Valadares F, Reis MC, Goncalves DR, Menezes Mda C. The effects of dietary supplementation with Agaricales mushrooms and other medicinal fungi on breast cancer: evidence-based medicine. Clinics (Sao Paulo, Brazil).2011;66(12):2133-2139.

O'Carrigan B, Wong MH, Willson ML, Stockler MR, Pavlakis N, Goodwin A. Bisphosphonates and other bone agents for breast cancer. The Cochrane database of systematic reviews. Oct 30 2017;10:Cd003474.

O'Connor MK, Morrow MMB, Hunt KN, Boughey JC, Wahner-Roedler DL, Conners AL, . . . Hruska CB. Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer. EJNMMI research.Dec 2017;7(1):5.

Ocean AJ, Starodub AN, Bardia A, Vahdat LT, Isakoff SJ, Guarino M, . . . Goldenberg DM. Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics. Cancer.Oct 01 2017;123(19):3843-3854.

Ogunleye AA, Xue F, Michels KB. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat.Jan 2010;119(2):477-484.

Oh JK, Sandin S, Strom P, Lof M, Adami HO, Weiderpass E. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. International journal of cancer.Oct 15 2015;137(8):1979-1989.

Ohmoto A, Yachida S. Current status of poly(ADP-ribose) polymerase inhibitors and future directions. OncoTargets and therapy.2017;10:5195-5208.

Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, . . . Naume B. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up. Breast cancer research: BCR.Nov 14 2017;19(1):120.

Ojeda-Fournier H, Nguyen JQ. How to improve your breast cancer program: Standardized reporting using the new American College of Radiology Breast Imaging-Reporting and Data System. The Indian journal of radiology & imaging.Oct-Dec 2009;19(4):266-277.

Olin JL, St Pierre M. Aromatase inhibitors in breast cancer prevention. Ann Pharmacother.Dec 2014;48(12):1605-1610.

Omofoye TS, Martaindale S, Teichgraeber DC, Parikh JR. Implementation of Upright Digital Breast Tomosynthesis-guided Stereotactic Biopsy. Academic radiology.Nov 2017;24(11):1451-1455.

Omranipour R, Kazemian A, Alipour S, Najafi M, Alidoosti M, Navid M, . . . Izadi S. Comparison of the Accuracy of Thermography and Mammography in the Detection of Breast Cancer. Breast care (Basel, Switzerland).Aug 2016;11(4):260-264.

OpenStax College. Breast Anatomy. Wikimedia Commons. 2013.

Opsomer D, van Landuyt K. Indications and Controversies for Nonabdominally-Based Complete Autologous Tissue Breast Reconstruction. Clinics in plastic surgery.Jan 2018;45(1):93-100.

P.D.Q. Supportive Palliative Care Editorial Board. Lymphedema (PDQ(R)): Health Professional Version. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002.

Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Lang I, . . . Francis PA. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med.Jul 10 2014;371(2):107-118.

Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, . . . Wolmark N. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol.Aug 10 2006;24(23):3726-3734.

Paixao E, Oliveira ACM, Pizato N, Muniz-Junqueira MI, Magalhaes KG, Nakano EY, Ito MK. The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment naive breast cancer patients: a randomized double-blind controlled trial. Nutr J.Oct 23 2017;16(1):71.

Palacios S, Mejia A. Progestogen safety and tolerance in hormonal replacement therapy. Expert opinion on drug safety.Nov 2016;15(11):1515-1525.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, . . . Hayes DF. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med.Nov 09 2017;377(19):1836-1846.

Panchal H, Matros E. Current Trends in Postmastectomy Breast Reconstruction. Plastic and reconstructive surgery.Nov 2017;140(5S Advances in Breast Reconstruction):7s-13s.

Panda AK, Chakraborty D, Sarkar I, Khan T, Sa G. New insights into therapeutic activity and anticancer properties of curcumin. Journal of experimental pharmacology.2017;9:31-45.

Parada H, Jr., Steck SE, Bradshaw PT, Engel LS, Conway K, Teitelbaum SL, . . . Gammon MD. Grilled, Barbecued, and Smoked Meat Intake and Survival Following Breast Cancer. J Natl Cancer Inst.Jun 2017;109(6).

Park YM, White AJ, Nichols HB, O'Brien KM, Weinberg CR, Sandler DP. The association between metabolic health, obesity phenotype and the risk of breast cancer. International journal of cancer. Journal international du cancer.Jun 15 2017;140(12):2657-2666.

Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review). International journal of oncology.Jan 2007;30(1):233-245.

Paterson R, Phillips KA. Genetic testing in women with breast cancer: implications for treatment. Expert review of anticancer therapy.Nov 2017;17(11):991-1002.

Patterson RE. Flaxseed and breast cancer: what should we tell our patients? Journal of clinical oncology: official journal of the American Society of Clinical Oncology.Oct 01 2011;29(28):3723-3724.

Patterson RE, Flatt SW, Newman VA, Natarajan L, Rock CL, Thomson CA, . . . Pierce JP. Marine fatty acid intake is associated with breast cancer prognosis. The Journal of nutrition.Feb 2011;141(2):201-206.

Pawlik A, Wiczk A, Kaczynska A, Antosiewicz J, Herman-Antosiewicz A. Sulforaphane inhibits growth of phenotypically different breast cancer cells. European journal of nutrition.Dec 2013;52(8):1949-1958.

PDQ Adult Treatment Editorial Board. Breast Cancer Treatment (PDQ(R)): Health Professional Version. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2017.

PDQ Screening Prevention Editorial Board. Breast Cancer Prevention (PDQ(R)): Health Professional Version. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2017a.

PDQ Screening Prevention Editorial Board. Breast Cancer Screening (PDQ(R)): Health Professional Version. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2017b.

Penniecook-Sawyers JA, Jaceldo-Siegl K, Fan J, Beeson L, Knutsen S, Herring P, Fraser GE. Vegetarian dietary patterns and the risk of breast cancer in a low-risk population. The British journal of nutrition.May 28 2016;115(10):1790-1797.

Perkins MS, Louw-du Toit R, Africander D. A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-alpha and -beta. The Journal of steroid biochemistry and molecular biology.Jul 22 2017.

Petrelli F, Tomasello G, Barni S, Lonati V, Passalacqua R, Ghidini M. Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature. Breast Cancer Res Treat.Nov 2017;166(2):339-349.

Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews(R). Seattle (WA): University of Washington, Seattle. Last updated 12/15/2016. Accessed 2/14/2018.

Pizzuti L, Vici P, Di Lauro L, Sergi D, Della Giulia M, Marchetti P, . . . Barba M. Metformin and breast cancer: basic knowledge in clinical context. Cancer treatment reviews.May 2015;41(5):441-447.

Platt J, Zhong T. Patient-Centered Breast Reconstruction Based on Health-Related Quality-of-Life Evidence. Clinics in plastic surgery.Jan 2018;45(1):137-143.

Poole EM, Shu X, Caan BJ, Flatt SW, Holmes MD, Lu W, . . . Chen WY. Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat.Jun 2013;139(2):529-537.

Popolo A, Pinto A, Daglia M, Nabavi SF, Farooqi AA, Rastrelli L. Two likely targets for the anti-cancer effect of indole derivatives from cruciferous vegetables: PI3K/Akt/mTOR signalling pathway and the aryl hydrocarbon receptor. Seminars in cancer biology.Oct 2017;46:132-137.

Posner MC, Wolmark N. Non-invasive breast carcinoma. Breast Cancer Res Treat.1992;21(3):155-164.

Post TA. FDA Grants Breakthrough Therapy Designation to DS-8201 for HER2-Positive Metastatic Breast Cancer. August 30, 2017.Accessed Dec 21, 2017.

Prapa M, Solomons J, Tischkowitz M. The use of panel testing in familial breast and ovarian cancer. Clinical medicine (London, England).Dec 2017;17(6):568-572.

Prat A, Lluch A, Turnbull AK, Dunbier AK, Calvo L, Albanell J, . . . Alba E. A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse. Clinical cancer research: an official journal of the American Association for Cancer Research.Jun 15 2017;23(12):3035-3044.

Provencher L, Hogue JC, Desbiens C, Poirier B, Poirier E, Boudreau D, . . . Chiquette J. Is clinical breast examination important for breast cancer detection? Current oncology (Toronto, Ont.).Aug 2016;23(4):e332-339.

Quigley D, Alumkal JJ, Wyatt AW, Kothari V, Foye A, Lloyd P, . . . Feng FY. Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors. Cancer Discov.Sep 2017;7(9):999-1005.

Rafferty EA, Park JM, Philpotts LE, Poplack SP, Sumkin JH, Halpern EF, Niklason LT. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology.Jan 2013;266(1):104-113.

Rafieian-Kopaei M, Movahedi M. Breast cancer chemopreventive and chemotherapeutic effects of Camellia Sinensis (green tea): an updated review. Electron Physician.Feb 2017;9(2):3838-3844.

Rakovitch E, Nofech-Mozes S, Hanna W, Narod S, Thiruchelvam D, Saskin R, . . . Paszat L. HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. British journal of cancer.Mar 13 2012;106(6):1160-1165.

Ramirez-Torres A, Rodriguez-Ramos R, Sabina FJ, Garcia-Reimbert C, Penta R, Merodio J, . . . Preziosi L. The role of malignant tissue on the thermal distribution of cancerous breast. J Theor Biol. Aug 7 2017;426:152-161.

Rampurwala M, Wisinski KB, O'Regan R. Role of the androgen receptor in triple-negative breast cancer. Clinical advances in hematology & oncology: H&O.Mar 2016;14(3):186-193.

Rastelli AL, Taylor ME, Gao F, Armamento-Villareal R, Jamalabadi-Majidi S, Napoli N, Ellis MJ. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat.Aug 2011;129(1):107-116.

Rayman MP. The importance of selenium to human health. Lancet. Jul 15 2000;356(9225):233-241.

Recht A. Radiation-Induced Heart Disease After Breast Cancer Treatment: How Big a Problem, and How Much Can-and Should-We Try to Reduce It? Journal of clinical oncology: official journal of the American Society of Clinical Oncology.Apr 10 2017;35(11):1146-1148.

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, . . . Edge SB. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. Dec 20 2016;34(36):4431-4442.

Reese DE, Henderson MC, Silver M, Mulpuri R, Letsios E, Tran Q, Wolf JK. Breast density does not impact the ability of Videssa(R) Breast to detect breast cancer in women under age 50. PloS one.2017;12(10):e0186198.

Reiter RJ, Rosales-Corral SA, Tan DX, Acuna-Castroviejo D, Qin L, Yang SF, Xu K. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis. International journal of molecular sciences.Apr 17 2017;18(4).

Ren S, Lien EJ. Natural products and their derivatives as cancer chemopreventive agents. Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.1997;48:147-171.

Ricci JA, Epstein S, Momoh AO, Lin SJ, Singhal D, Lee BT. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. The Journal of surgical research. Oct 2017;218:108-116.

Richie JP, Jr., Das A, Calcagnotto AM, Sinha R, Neidig W, Liao J, . . . El-Bayoumy K. Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial. Cancer prevention research (Philadelphia, Pa.).Aug 2014;7(8):796-804.

Ricks-Santi LJ, McDonald JT. Low utility of Oncotype DX(R) in the clinic. Cancer Med.Mar 2017;6(3):501-507.

Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes K, Wheeler SB. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY. International journal of technology assessment in health care.Jan 2016;32(5):355-361.

Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, . . . Conte P. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N Engl J Med.Aug 10 2017;377(6):523-533.

Rock CL, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Newman VA, . . . Pierce JP. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology.Sep 20 2005;23(27):6631-6638.

Ronco AL, De Stefani E, Deneo-Pellegrini H, Quarneti A. Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay. Asian Pacific journal of cancer prevention: APJCP.2012;13(1):139-146.

Rostami R, Mittal S, Rostami P, Tavassoli F, Jabbari B. Brain metastasis in breast cancer: a comprehensive literature review. Journal of neuro-oncology.May 2016;127(3):407-414.

Royce ME, Osman D. Everolimus in the Treatment of Metastatic Breast Cancer. Breast cancer: basic and clinical research. 2015;9:73-79.

Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, . . . Ganz PA. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: a cancer journal for clinicians.Jan-Feb 2016;66(1):43-73.

Saha P, Nanda R. Concepts and targets in triple-negative breast cancer: recent results and clinical implications. Therapeutic advances in medical oncology.Sep 2016;8(5):351-359.

Sahota S, Vahdat LT. Sacituzumab govitecan: an antibody-drug conjugate. Expert Opin Biol Ther.Aug 2017;17(8):1027-1031.

Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? International immunology. October 1, 2009 2009;21(10):1105-1111.

Samavat H, Ursin G, Emory TH, Lee E, Wang R, Torkelson CJ, . . . Kurzer MS. A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer. Cancer prevention research (Philadelphia, Pa.). Dec 2017;10(12):710-718.

Samuelsson LB, Bovbjerg DH, Roecklein KA, Hall MH. Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review. Neuroscience and biobehavioral reviews. Oct 13 2017;84:35-48.

Saraiva DP, Guadalupe Cabral M, Jacinto A, Braga S. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment. ESMO open. 2017;2(4):e000208.

Sardanelli F, Aase HS, Alvarez M, Azavedo E, Baarslag HJ, Balleyguier C, . . . Forrai G. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. European radiology. Jul 2017;27(7):2737-2743.

Sau S, Alsaab HO, Kashaw SK, Tatiparti K, Iyer AK. Advances in antibody-drug conjugates: A new era of targeted cancer therapy. Drug discovery today. Oct 2017;22(10):1547-1556.

Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, . . . van Leeuwen FE. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. N Engl J Med. Dec 24 2015;373(26):2499-2511.

Schillaci O, Spanu A, Danieli R, Madeddu G. Molecular breast imaging with gamma emitters. Q J Nucl Med Mol Imaging. Dec 2013;57(4):340-351.

Schottenfeld D, Fraumeni JF. Cancer Epidemiology and Prevention. Oxford University Press; 2006.

Schramm A, Friedl TW, Schochter F, Scholz C, de Gregorio N, Huober J, . . . Fehm T. Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program. Archives of gynecology and obstetrics. Feb 2016;293(2):271-281.

Schwartzberg LS, Yardley DA, Elias AD, Patel M, LoRusso P, Burris HA, . . . Traina TA. A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. Aug 01 2017;23(15):4046-4054.

Scully R. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast cancer research: BCR. 2000;2(5):324-330.

Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, Kaaks R, . . . Chang-Claude J. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis. International journal of cancer. Journal international du cancer. Aug 15 2014;135(4):923-933.

Seigneurin A, Labarere J, Francois O, Exbrayat C, Dupouy M, Filippi M, Colonna M. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data. Breast (Edinburgh, Scotland). Aug 2016;28:60-66.

Seo HS, Ku JM, Choi HS, Woo JK, Lee BH, Kim DS, . . . Ko SG. Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells. Oncology reports. Aug 2017;38(2):715-724.

Sgroi DC, Sestak I, Cuzick J, Zhang Y, Schnabel CA, Schroeder B, . . . Dowsett M. Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population. The Lancet. Oncology. Oct 2013;14(11):1067-1076.

Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, . . . Woodward WA. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. Journal of Cancer. 2017;8(11):2026-2032.

Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat. Apr 2005;90(3):263-271.

Shankar RA, Nibhanupudy JR, Sridhar R, Ashton C, Goldson AL. Immediate breast reconstruction-impact on radiation management. Journal of the National Medical Association. Apr 2003;95(4):286-295.

Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various types and management of breast cancer: an overview. Journal of advanced pharmaceutical technology & research. Apr 2010;1(2):109-126.

Sharma P, McClees SF, Afaq F. Pomegranate for Prevention and Treatment of Cancer: An Update. Molecules (Basel, Switzerland). Jan 24 2017;22(1).

Shikhman R, Keppke AL. Breast, Imaging, Reporting and Data System (BI RADS). StatPearls. Treasure Island (FL): StatPearls Publishing, LLC.; 2017.

Shimada K, Matsuda S, Jinno H, Kameyama N, Konno T, Arai T, . . . Kitagawa Y. The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin. Biomed Res Int. 2017;2017:7412865.

Shivappa N, Sandin S, Lof M, Hebert JR, Adami HO, Weiderpass E. Prospective study of dietary inflammatory index and risk of breast cancer in Swedish women. British journal of cancer. Sep 29 2015;113(7):1099-1103.

Shoaib M, Ahmed SA. Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment. Breast cancer (Dove Medical Press). 2016;8:241-242.

Shokryzadan P, Rajion MA, Meng GY, Boo LJ, Ebrahimi M, Royan M, . . . Jahromi MF. Conjugated linoleic acid: A potent fatty acid linked to animal and human health. Critical reviews in food science and nutrition. Sep 2 2017;57(13):2737-2748.

Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, Lu W. Soy food intake and breast cancer survival. Jama. Dec 09 2009;302(22):2437-2443.

Silva FX, Katz L, Souza AS, Amorim MM. Mammography in asymptomatic women aged 40-49 years. Revista de saude publica. Dec 2014;48(6):931-939.

Sinha D, Biswas J, Nabavi SM, Bishayee A. Tea phytochemicals for breast cancer prevention and intervention: From bench to bedside and beyond. Semin Cancer Biol. Oct 2017;46:33-54.

Sinha D, Biswas J, Sung B, Aggarwal BB, Bishayee A. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr Drug Targets. Dec 2012;13(14):1799-1819.

Sinha R, Kiley SC, Lu JX, Thompson HJ, Moraes R, Jaken S, Medina D. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer letters. Nov 15 1999;146(2):135-145.

Sinha R, Medina D. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. Carcinogenesis. Aug 1997;18(8):1541-1547.

Slomski A. Low-Fat Diet Reduces Mortality After Breast Cancer. Jama. Sep 26 2017;318(12):1099.

Smania MA. Evaluation of common breast complaints in primary care. The Nurse practitioner. Oct 18 2017;42(10):8-15.

Sofi NY, Jain M, Kapil U, Seenu V, R L, Yadav CP, . . . Sareen N. Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study. The Journal of steroid biochemistry and molecular biology. Nov 11 2017.

Solinas C, Gombos A, Latifyan S, Piccart-Gebhart M, Kok M, Buisseret L. Targeting immune checkpoints in breast cancer: an update of early results. ESMO open. 2017;2(5):e000255.

Sonnenblick A, Agbor-Tarh D, Bradbury I, Di Cosimo S, Azim HA, Jr., Fumagalli D, . . . de Azambuja E. Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. May 01 2017;35(13):1421-1429.

Soyfoods Association. Sales and Trends Soy Products. Sales and Trends. In: Consumer Attitudes About Nutrition, Health and Soyfoods. Copyright 2014. Accessed 2/13/2018.

Steck SE, Gaudet MM, Eng SM, Britton JA, Teitelbaum SL, Neugut AI, . . . Gammon MD. Cooked meat and risk of breast cancer--lifetime versus recent dietary intake. Epidemiology (Cambridge, Mass.). May 2007;18(3):373-382.

Steelman LS, Martelli AM, Cocco L, Libra M, Nicoletti F, Abrams SL, McCubrey JA. The therapeutic potential of mTOR inhibitors in breast cancer. Br J Clin Pharmacol. Nov 2016;82(5):1189-1212.

Stemmer SM, Steiner M, Rizel S, Soussan-Gutman L, Ben-Baruch N, Bareket-Samish A, . . . Liebermann N. Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry. NPJ breast cancer. 2017;3:33.

Stoll BA. Breast cancer and the western diet: role of fatty acids and antioxidant vitamins. European journal of cancer (Oxford, England : 1990). Nov 1998a;34(12):1852-1856.

Stoll BA. Western diet, early puberty, and breast cancer risk. Breast Cancer Res Treat. Jun 1998b;49(3):187-193.

Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. The Journal of nutritional biochemistry. Jun 2015;26(6):675-685.

Sud A, Thomsen H, Sundquist K, Houlston RS, Hemminki K. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. May 10 2017;35(14):1584-1590.

Sulaiman S, Shahril MR, Wafa SW, Shaharudin SH, Hussin SN. Dietary carbohydrate, fiber and sugar and risk of breast cancer according to menopausal status in Malaysia. Asian Pacific journal of cancer prevention: APJCP. 2014;15(14):5959-5964.

Sun C, Rosendahl AH, Wang XD, Wu DQ, Andersson R. Polysaccharide-K (PSK) in cancer--old story, new possibilities? Current medicinal chemistry. 2012;19(5):757-762.

Sung B, Chung HY, Kim ND. Role of Apigenin in Cancer Prevention via the Induction of Apoptosis and Autophagy. Journal of cancer prevention. Dec 2016;21(4):216-226.

Suzuki KT, Tsuji Y, Ohta Y, Suzuki N. Preferential organ distribution of methylselenol source Se-methylselenocysteine relative to methylseleninic acid. Toxicology and applied pharmacology. Feb 15 2008;227(1):76-83.

Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H. Differential apoptotic response of human cancer cells to organoselenium compounds. Cancer chemotherapy and pharmacology. Aug 2010;66(3):475-484.

Tabung FK, Steck SE, Liese AD, Zhang J, Ma Y, Caan B, . . . Hebert JR. Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women's Health Initiative. British journal of cancer. May 24 2016;114(11):1277-1285.

Tafazoli A. Coenzyme Q10 in breast cancer care. Future oncology (London, England). May 2017;13(11):1035-1041.

Takahashi K, Okada M, Ozaki T, Kurioka H, Manabe A, Kanasaki H, Miyazaki K. Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause. Human reproduction (Oxford, England). May 2000;15(5):1028-1036.

Takaoka M, Miki Y. BRCA1 gene: function and deficiency. Int J Clin Oncol. Sep 07 2017.

Takeuchi H, Kawanaka H, Fukuyama S, Kubo N, Hiroshige S, Yano T. Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer. PloS one. 2017;12(5):e0177137.

Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B. Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics. 2016;8:115.

Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, . . . McGale P. Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. May 20 2017;35(15):1641-1649.

Thamm OC, Andree C. Immediate Versus Delayed Breast Reconstruction: Evolving Concepts and Evidence Base. Clinics in plastic surgery. Jan 2018;45(1):119-127.

Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. May 15 2005;11(10):3828-3835.

Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, . . . Thompson PA. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat. Aug 2017;165(1):97-107.

Thomson CA, Ho E, Strom MB. Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies. Nutrition reviews. Jul 2016;74(7):432-443.

Tin AS, Park AH, Sundar SN, Firestone GL. Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells. BMC biology. Sep 12 2014;12:72.

Tinggi U. Selenium: its role as antioxidant in human health. Environ Health Prev Med. Mar 2008;13(2):102-108.

Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, . . . Lansky EP. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis. 2003;6(2):121-128.

Toland AE, Andreassen PR. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment. Journal of medical genetics. Nov 2017;54(11):721-731.

Torkelson CJ, Sweet E, Martzen MR, Sasagawa M, Wenner CA, Gay J, . . . Standish LJ. Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. ISRN oncology. 2012;2012:251632.

Trail PA, Dubowchik GM, Lowinger TB. Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design. Pharmacology & therapeutics. Jul 27 2017.

Tremblay D, Patel V, Fifer KM, Caro J, Kolodka O, Mandelli J, Shapiro CL. Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Jan 2018;26(1):197-202.

Tsekouras A, Mantas D, Tsilimigras DI, Ntanasis-Stathopoulos I, Kontos M, Zografos GC. Adipose-derived stem cells for breast reconstruction after breast surgery - preliminary results. Case reports in plastic surgery & hand surgery. 2017;4(1):35-41.

Tseng TH, Chien MH, Lin WL, Wen YC, Chow JM, Chen CK, . . . Lee WJ. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21(WAF1/CIP1) expression. Environmental toxicology. Feb 2017;32(2):434-444.

Turner NC, Ro J, Andre F, Loi S, Verma S, Iwata H, . . . Cristofanilli M. Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer. N Engl J Med. Jul 16 2015;373(3):209-219.

U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2014 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2017.

Uetaki M, Tabata S, Nakasuka F, Soga T, Tomita M. Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress. Scientific reports. Sep 9 2015;5:13896.

US Preventive Services Task Force. Final Recommendation Statement: Breast Cancer Screening, 1/2016. Accessed 01/29/2018.

Vahid F, Hatami M, Sadeghi M, Ameri F, Faghfoori Z, Davoodi SH. The association between the Index of Nutritional Quality (INQ) and breast cancer and the evaluation of nutrient intake of breast cancer patients: A case-control study. Nutrition (Burbank, Los Angeles County, Calif.). Jan 2018;45:11-16.

Valadares F, Garbi Novaes MR, Canete R. Effect of Agaricus sylvaticus supplementation on nutritional status and adverse events of chemotherapy of breast cancer: a randomized, placebo-controlled, double-blind clinical trial. Indian journal of pharmacology. May-Jun 2013;45(3):217-222.

Valencia OM, Samuel SE, Viscusi RK, Riall TS, Neumayer LA, Aziz H. The Role of Genetic Testing in Patients With Breast Cancer: A Review. JAMA surgery. Jun 1 2017;152(6):589-594.

van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, . . . Hunter DJ. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. Sep 15 2000;152(6):514-527.

van Schoor N, Lips P. Global Overview of Vitamin D Status. Endocrinology and metabolism clinics of North America. Dec 2017;46(4):845-870.

Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, . . . Galluzzi L. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 2017;6(11):e1373237.

Vatovec C, Erten MZ, Kolodinsky J, Brown P, Wood M, James T, Sprague BL. Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society. Critical reviews in eukaryotic gene expression. 2014;24(4):281-286.

Vaughan RA, Garcia-Smith R, Dorsey J, Griffith JK, Bisoffi M, Trujillo KA. Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. International journal of cancer. Nov 15 2013;133(10):2504-2510.

Venkitaraman R. Lobular neoplasia of the breast. The breast journal. Sep-Oct 2010;16(5):519-528.

Viale G, de Snoo FA, Slaets L, Bogaerts J, van 't Veer L, Rutgers EJ, . . . Cardoso F. Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial. Breast Cancer Res Treat. Sep 19 2017.

Vibet S, Goupille C, Bougnoux P, Steghens JP, Gore J, Maheo K. Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response. Free radical biology & medicine. Apr 1 2008;44(7):1483-1491.

Vinod BS, Antony J, Nair HH, Puliyappadamba VT, Saikia M, Narayanan SS, . . . Anto RJ. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil. Cell death & disease. Feb 21 2013;4:e505.

Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer letters. Aug 18 2009;281(1):1-7.

Waked K, Colle J, Doornaert M, Cocquyt V, Blondeel P. Systematic review: The oncological safety of adipose fat transfer after breast cancer surgery. Breast (Edinburgh, Scotland). Feb 2017;31:128-136.

Wakimoto R, Ono M, Takeshima M, Higuchi T, Nakano S. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells. Anticancer research. Nov 2017;37(11):6153-6159.

Wallner LP, Li Y, McLeod MC, Hamilton AS, Ward KC, Veenstra CM, . . . Hawley ST. Decision-support networks of women newly diagnosed with breast cancer. Cancer. Oct 15 2017;123(20):3895-3903.

Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis. Breast (Edinburgh, Scotland). Feb 2017;31:157-166.

Wang R, Li X, Zhang H, Wang K, He J. Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker. Oncotarget. Sep 26 2017;8(43):75742-75755.

Wang W, Lv M, Wang Y, Zhang J. Development of novel application of 3,3'-diindolylmethane: sensitizing multidrug resistance human breast cancer cells to gamma-irradiation. Pharmaceutical biology. Dec 2016;54(12):3164-3168.

Wang Y, Yu J, Cui R, Lin J, Ding X. Curcumin in Treating Breast Cancer: A Review. Journal of laboratory automation. Dec 2016;21(6):723-731.

Weiderpass E, Baron JA, Adami HO, Magnusson C, Lindgren A, Bergstrom R, . . . Persson I. Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet. May 29 1999;353(9167):1824-1828.

Weiss GJ, Waypa J, Blaydorn L, Coats J, McGahey K, Sangal A, . . . Khemka V. A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus). British journal of cancer. Jun 27 2017;117(1):33-40.

White AJ, Bradshaw PT, Herring AH, Teitelbaum SL, Beyea J, Stellman SD, . . . Gammon MD. Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. Environ Int. Apr-May 2016;89-90:185-192.

White AJ, Chen J, Teitelbaum SL, McCullough LE, Xu X, Hee Cho Y, . . . Gammon MD. Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer. Environ Res. Feb 2016;145:93-100.

White RR, Halperin TJ, Olson JA, Jr., Soo MS, Bentley RC, Seigler HF. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg. Jun 2001;233(6):769-777.

Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Annals of nutrition & metabolism. 2006;50(2):85-94.

Wishart GC, Campisi M, Boswell M, Chapman D, Shackleton V, Iddles S, . . . Britton PD. The accuracy of digital infrared imaging for breast cancer detection in women undergoing breast biopsy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. Jun 2010;36(6):535-540.

Wong CK, Bao YX, Wong EL, Leung PC, Fung KP, Lam CW. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. The American journal of Chinese medicine. 2005;33(3):381-395.

Wootten AC, Abbott JM, Siddons HM, Rosenthal MA, Costello AJ. A qualitative assessment of the experience of participating in a cancer-related clinical trial. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. Jan 2011;19(1):49-55.

Wu M, Liu L, Chan C. Identification of novel targets for breast cancer by exploring gene switches on a genome scale. BMC genomics. Nov 3 2011;12:547.

Xu HB, Liu YJ, Li L. Aromatase inhibitor versus tamoxifen in postmenopausal woman with advanced breast cancer: a literature-based meta-analysis. Clinical breast cancer. Aug 2011;11(4):246-251.

Xu Y, Xin Y, Diao Y, Lu C, Fu J, Luo L, Yin Z. Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PloS one. 2011;6(12):e29169.

Yaghjyan L, Colditz GA. Estrogens in the breast tissue: a systematic review. Cancer Causes Control. Apr 2011;22(4):529-540.

Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, . . . Ueno NT. Inflammatory breast cancer: what we know and what we need to learn. Oncologist. 2012;17(7):891-899.

Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, . . . Kushi LH. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. Mar 1 2017;3(3):351-357.

Yardley DA. Drug resistance and the role of combination chemotherapy in improving patient outcomes. Int J Breast Cancer. 2013;2013:137414.

Yasuda MT, Sakakibara H, Shimoi K. Estrogen- and stress-induced DNA damage in breast cancer and chemoprevention with dietary flavonoid. Genes and environment: the official journal of the Japanese Environmental Mutagen Society. 2017;39:10.

Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, . . . Meric-Bernstam F. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer prevention research (Philadelphia, Pa.). Aug 2010;3(8):1026-1034.

Yip CH, Rhodes A. Estrogen and progesterone receptors in breast cancer. Future oncology (London, England). Nov 2014;10(14):2293-2301.

Yu LY, Tang J, Zhang CM, Zeng WJ, Yan H, Li MP, Chen XP. New Immunotherapy Strategies in Breast Cancer. International journal of environmental research and public health. Jan 12 2017;14(1).

Yu SS, Spicer DV, Hawes D, Tseng CC, Yang CS, Pike MC, Wu AH. Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients. Frontiers in oncology. 2013;3:298.

Yu X, Hu G, Zhang Z, Qiu F, Shao X, Wang X, . . . Huang J. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women. BMC cancer. Jul 11 2016;16:450.

Yun MR, Song M, Jung KH, Yu BJ, Lee KJ. The Effects of Mind Subtraction Meditation on Breast Cancer Survivors' Psychological and Spiritual Well-being and Sleep Quality: A Randomized Controlled Trial in South Korea. Cancer nursing. Sep/Oct 2017;40(5):377-385.

Zangardi ML, Spring LM, Blouin GC, Bardia A. Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. Expert Rev Clin Pharmacol. Nov 2017;10(11):1169-1176.

Zervoudis S, Iatrakis G, Tomara E, Bothou A, Papadopoulos G, Tsakiris G. Main controversies in breast cancer. World journal of clinical oncology. Aug 10 2014;5(3):359-373.

Zhang A, Li P, Liu Q, Song S. Breast-specific gamma camera imaging with 99mTc-MIBI has better diagnostic performance than magnetic resonance imaging in breast cancer patients: A meta-analysis. Hellenic journal of nuclear medicine. Jan-Apr 2017;20(1):26-35.

Zhang BN, Cao XC, Chen JY, Chen J, Fu L, Hu XC, . . . Zhang J. Guidelines on the diagnosis and treatment of breast cancer (2011 edition). Gland surgery. May 2012;1(1):39-61.

Zhang FF, Haslam DE, Terry MB, Knight JA, Andrulis IL, Daly MB, . . . John EM. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry. Cancer. Jun 01 2017;123(11):2070-2079.

Zhang G, Wang Y, Zhang Y, Wan X, Li J, Liu K, . . . Wu E. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Current molecular medicine. Feb 2012;12(2):163-176.

Zhang HG, Kim H, Liu C, Yu S, Wang J, Grizzle WE, . . . Barnes S. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochimica et biophysica acta. Jul 2007;1773(7):1116-1123.

Zhang YF, Kang HB, Li BL, Zhang RM. Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pacific journal of cancer prevention : APJCP. 2012;13(2):479-482.

Zhang Z, Atwell LL, Farris PE, Ho E, Shannon J. Associations between cruciferous vegetable intake and selected biomarkers among women scheduled for breast biopsies. Public health nutrition. May 2016;19(7):1288-1295.

Zhao H, Zhang Q, Zhao L, Huang X, Wang J, Kang X. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evidence-based complementary and alternative medicine: eCAM. 2012;2012:809614.

Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, . . . Yu J. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy. The British journal of radiology. 2016;89(1058):20150665.

Zhong X, Wu K, He S, Ma S, Kong L. [Effects of quercetin on the proliferation and apoptosis in transplantation tumor of breast cancer in nude mice]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. Jul 2003;34(3):439-442.

Zhou L, Dicker DT, Matthew E, El-Deiry WS, Alpaugh RK. Circulating tumor cells: silent predictors of metastasis. F1000Research. 2017;6.

Zhu W, Jia L, Chen G, Zhao H, Sun X, Meng X, . . . Zheng M. Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy. Oncotarget. Jul 26 2016;7(30):48607-48613.

Zurrida S, Veronesi U. Milestones in breast cancer treatment. The breast journal. Jan-Feb 2015;21(1):3-12.